AI assistant
PFIZER INC — Director's Dealing 2019
Mar 2, 2019
29831_dirs_2019-03-01_f53191af-6154-4eb3-8ae0-54a5dfd821e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-27
Reporting Person: DAMELIO FRANK A (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-27 | Common Stock | M | 182247.0000 | $32.2300 | Acquired | 588177.0000 | Direct |
| 2019-02-27 | Common Stock | A | 96183.0000 | $0.0000 | Acquired | 684360.0000 | Direct |
| 2019-02-27 | Common Stock | F | 34131.0000 | $42.9300 | Disposed | 650229.0000 | Direct |
| 2019-02-27 | Common Stock | F | 47101.0000 | $42.9300 | Disposed | 603128.0000 | Direct |
| 2019-02-27 | Common Stock | F | 112552.0000 | $42.3100 | Disposed | 490576.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-27 | Stock Appreciation Rights | $32.2300 | M | 182247.0000 | Disposed | 2019-02-27 | Common Stock (182247.0000) | Direct |
| 2019-02-28 | Stock Appreciation Rights | $43.3500 | A | 180503.0000 | Acquired | 2024-02-28 | Common Stock (180503.0000) | Direct |
| 2019-02-28 | Stock Appreciation Rights | $43.3500 | A | 152114.0000 | Acquired | 2026-02-28 | Common Stock (152114.0000) | Direct |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F5: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F6: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F8: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.